NeoPlex COVID-19 Detection Kit

Manufactured by GeneMatrix Inc., South Korea - www.genematrix.net/

Device identification number

657

CE Marking

✓Yes

HSC common list (RAT)

×No

Format

Manual

Target type

Nucleic acid

Commercial Status

Commercialised

Last Update

2022-08-24 09:08:01 CET

Assay Type

Nucleic acid-PCR

Method

RT-PCR

Time

180 minutes

Positive control

Positive control not specified

Negative control

Negative control not specified

Throughput

single tubes

Notes

http://genematrix.net/2018/subpage.php?p=m1_2_neoplexCOVID19

Related Scientific Literature

Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
COVID-19 Experience: First Italian Survey on Healthcare Staff Members from a Mother-Child Research Hospital Using Combined Molecular and Rapid Immunoassay Tests

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements

COVID-19 In Vitro Diagnostic Medical Device - detail

Related Scientific Literature